Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

The level of cellular and molecular complexity of the nervous system creates unique problems for the neuroscientist in the design and implementation of functional genomic studies. Microarray technologies can be powerful, with limitations, when applied to the analysis of human brain disorders. Recently, using cDNA microarrays, altered gene expression patterns between subjects with schizophrenia and controls were shown. Functional data mining led to two novel discoveries: a consistent decrease in the group of transcripts encoding proteins that regulate presynaptic function; and the most changed gene, which has never been previously associated with schizophrenia, regulator of G-protein signaling 4. From these and other findings, a hypothesis has been formulated to suggest that schizophrenia is a disease of the synapse. In the context of a neurodevelopmental model, it is proposed that impaired mechanics of synaptic transmission in specific neural circuits during childhood and adolescence ultimately results in altered synapse formation or pruning, or both, which manifest in the clinical onset of the disease.

[1]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[2]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[3]  N. Lee,et al.  A concise guide to cDNA microarray analysis. , 2000, BioTechniques.

[4]  M. Tsuang.  Schizophrenia: genes and environment , 2000, Biological Psychiatry.

[5]  R. Nicoll,et al.  Rabphilin Knock-Out Mice Reveal That Rabphilin Is Not Required for Rab3 Function in Regulating Neurotransmitter Release , 1999, The Journal of Neuroscience.

[6]  A. Chenchik,et al.  Use of SMART-generated cDNA for gene expression studies in multiple human tumors. , 2001, BioTechniques.

[7]  B. Destenaves,et al.  New advances in pharmacogenomics. , 2000, Current opinion in chemical biology.

[8]  M. Ko,et al.  Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Südhof,et al.  Synaptic assembly of the brain in the absence of neurotransmitter secretion. , 2000, Science.

[10]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[11]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[12]  Daniel R. Weinberger,et al.  Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood , 1997, Psychopharmacology.

[13]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Walt,et al.  A fiber-optic DNA biosensor microarray for the analysis of gene expression , 1996, Nature Biotechnology.

[15]  D. Geschwind,et al.  Klinefelter's syndrome as a model of anomalous cerebral laterality: testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. , 1998, Developmental genetics.

[16]  P. Huttenlocher.  Synaptic density in human frontal cortex - developmental changes and effects of aging. , 1979, Brain research.

[17]  P. Brown,et al.  Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. , 1999, Nucleic acids research.

[18]  J. Trent,et al.  Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays , 1999 .

[19]  J A Frank,et al.  Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.

[20]  R. Harris,et al.  Gene expression in human alcoholism: microarray analysis of frontal cortex. , 2000, Alcoholism, clinical and experimental research.

[21]  J. Pierri,et al.  Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. , 1999, The American journal of psychiatry.

[22]  David J. Lockhart,et al.  Expressing what's on your mind: DNA arrays and the brain , 2001, Nature Reviews Neuroscience.

[23]  D. Geschwind,et al.  Mice, microarrays, and the genetic diversity of the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Pulver.  Search for schizophrenia susceptibility genes , 2000, Biological Psychiatry.

[25]  Jiasen Lu,et al.  Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. , 2000, Nucleic acids research.

[26]  T. Südhof,et al.  Essential functions of synapsins I and II in synaptic vesicle regulation , 1995, Nature.

[27]  L. Wodicka,et al.  Regional and strain-specific gene expression mapping in the adult mouse brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Mark Schena,et al.  Microarray Biochip Technology , 2000 .

[29]  David R. Walt,et al.  Bead-based Fiber-Optic Arrays , 2000, Science.

[30]  D. Weinberger,et al.  From neuropathology to neurodevelopment , 1995, The Lancet.

[31]  J. Lieberman,et al.  Serotonergic basis of antipsychotic drug effects in schizophrenia , 1998, Biological Psychiatry.

[32]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[33]  J. Claverie.  Computational methods for the identification of differential and coordinated gene expression. , 1999, Human molecular genetics.

[34]  E. Winzeler,et al.  Genomics, gene expression and DNA arrays , 2000, Nature.

[35]  Ash A. Alizadeh,et al.  'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns , 2000, Genome Biology.

[36]  D Haussler,et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[38]  N. Shen,et al.  Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays , 1996, Nature Medicine.

[39]  R. Tibshirani,et al.  Supervised harvesting of expression trees , 2001, Genome Biology.

[40]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[41]  N C Andreasen,et al.  Pieces of the Schizophrenia Puzzle Fall into Place , 1996, Neuron.

[42]  M. Erlander,et al.  TOGA: an automated parsing technology for analyzing expression of nearly all genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[44]  P. Brown,et al.  Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Webster,et al.  Application of cDNA microarrays to examine gene expression differences in schizophrenia , 2001, Brain Research Bulletin.

[46]  R L Stears,et al.  A novel, sensitive detection system for high-density microarrays using dendrimer technology. , 2000, Physiological genomics.

[47]  Robert C. Thompson,et al.  The “chip” as a specific genetic tool , 2000, Biological Psychiatry.

[48]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[49]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[50]  N. Andreasen,et al.  Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.

[51]  R. Duman,et al.  Region-Specific Regulation of RGS4 (Regulator of G-Protein–Signaling Protein Type 4) in Brain by Stress and Glucocorticoids: In Vivo and In VitroStudies , 1999, The Journal of Neuroscience.

[52]  S. P. Fodor,et al.  High density synthetic oligonucleotide arrays , 1999, Nature Genetics.

[53]  D. Richman,et al.  Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. , 1998, AIDS research and human retroviruses.

[54]  R. Drmanac,et al.  Accurate sequencing by hybridization for DNA diagnostics and individual genomics , 1998, Nature Biotechnology.

[55]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[56]  Irving L. Weissman,et al.  A Genetic Analysis of Neural Progenitor Differentiation , 2001, Neuron.

[57]  J. Collinge,et al.  Decreased Hippocampal Expression of a Glutamate Receptor Gene in Schizophrenia , 1991, British Journal of Psychiatry.

[58]  E. G. Jones,et al.  Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  L. Wodicka,et al.  Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.

[60]  P. Levitt,et al.  DNA microarrays and human brain disorders , 2001 .

[61]  David A Lewis,et al.  Catching Up on Schizophrenia Natural History and Neurobiology , 2000, Neuron.

[62]  S. Nelson,et al.  Linkage-disequilibrium mapping without genotyping , 1998, Nature Genetics.

[63]  M. Linial.  SNARE Proteins‐Why So Many, Why So Few? , 1997, Journal of neurochemistry.

[64]  S. Walker,et al.  Quantitative RT-PCR : Pitfalls and Potential , 1999 .

[65]  F. Collins,et al.  The Human Genome Project , 2001, Cancer.

[66]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[67]  D. Bowtell,et al.  Options available — from start to finish — for obtaining expression data by microarray , 1999, Nature Genetics.

[68]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.

[69]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[70]  J. Eberwine,et al.  Analysis of gene expression in single live neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[71]  T. Powell,et al.  An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat. , 1980, Brain : a journal of neurology.

[72]  T. Woo,et al.  A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Pevsner,et al.  High throughput analysis of gene expression in the human brain , 2000, Journal of Neuroscience Research.

[74]  B. Kirschbaum,et al.  Comparative gene-expression analysis. , 1999, Trends in biotechnology.

[75]  G. A. Whitmore,et al.  Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[77]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[78]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[79]  T. Südhof,et al.  Membrane fusion and exocytosis. , 1999, Annual review of biochemistry.

[80]  F. Bertucci,et al.  Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.

[81]  J. Weingarten,et al.  Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques , 1999, Annals of neurology.

[82]  Nello Cristianini,et al.  Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..

[83]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[84]  S. P. Fodor,et al.  Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis , 1996, Nature Genetics.

[85]  P. Törönen,et al.  Analysis of gene expression data using self‐organizing maps , 1999, FEBS letters.

[86]  A. Gilman,et al.  The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide Hydrolysis* , 1996, The Journal of Biological Chemistry.